Delivery Order SPE2DB24D2018-SPE2DB25FWXA0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections with a contract ceiling value of $47,883.19. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by August 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a ceiling value of $58,321.91 under firm fixed pricing. This is a non-set-aside competitively awarded delivery order with an ultimate completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injections with a ceiling value of $4,416.68. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competitive set-aside arrangement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $2,029.53 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. The contract carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $36,326.70 on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is scheduled for completion by September 29, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a contract ceiling value of $1,088.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation, reflecting open competition for...
- The Defense Logistics Agency awarded a $5,713.89 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injections on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a ceiling value of $4,871.43. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. This delivery order is issued under...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWXA0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injections with a contract ceiling value of $23,841.66. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and is scheduled for completion by September 26, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor supporting federal medical procurement. This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that enables comprehensive pharmaceutical and medical supply support for military healthcare systems globally. The company's extensive federal contract portfolio demonstrates its capability to deliver a diverse range of medications and medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Mounjaro, a diabetes management medication, aligns with AmerisourceBergen's established track record supplying specialty pharmaceuticals to federal customers through competitive procurement vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 9/25/25 |